GenDx
Desconocido
METHYLOMIC: DNA methylation markers to predict treatment success of biologicals in Crohn’s disease.
GENOME DIAGNOSTICS B.V
participó en un
HORIZON EUROPE:
HORIZON-HLTH-2022-TOOL-11
Monoclonal antibodies have become a mainstay of therapy in common immune-mediated diseases (IMID) including Crohn’s disease (CD), rheumatoid...
2022-11-24 - 2026-12-31 | Financiado
2022-11-24 - 2026-12-31 | Financiado
* No se disponen de datos de la empresa actual.